GlassScriptPhysician profile
Irene Roldan
NPI 1629545330
$2,850.01
in general payments reported to CMS, 2019-2025
19 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $298 · 2023: $983 · 2024: $917 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614 · Education: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.59 |
| Education | $474.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,087.36 | 2021-2024 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $646.96 | 2021-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $202.29 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $127.07 | 2022-2025 | Abre, In.Pact Admiral, In.Pact Av |
| Urovant Sciences INC | $122.36 | 2021-2022 | |
| Depuy Synthes Sales INC. | $120.27 | 2021 | |
| Pfizer INC. | $84.67 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $81.53 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $73.83 | 2021-2025 | Trelstar |
| Abbvie INC. | $63.10 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $45.83 | 2024 | |
| 180 Medical, INC. | $38.00 | 2023 | Gentlecath |
| Novartis Pharmaceuticals Corporation | $29.16 | 2022-2023 | |
| Axonics, INC. | $24.47 | 2024 | Axonics |
| Merck Sharp & Dohme LLC | $22.65 | 2023 | Keytruda, Lynparza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $21.94 | 2023 | |
| Myriad Genetic Laboratories, INC. | $21.12 | 2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $18.85 | 2024 | |
| Olympus America INC. | $18.55 | 2023 | Soltive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Roldan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.